MedPath

Evaluation of the prototype device for glucose monitoring by oral glucose tolerance test

Not Applicable
Recruiting
Conditions
ot applicable
Registration Number
JPRN-UMIN000053471
Lead Sponsor
APO PLUS STATION CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects who are on treatment for a serious illness. 2)Subjects who have been diagnosed with diabetes and under treatment or medication. 3)Subjects who are may develop allergies in connection with the oral glucose tolerance test. 4)Subjects who regularly use licensed drugs or quasi-drugs that may affect the study. 5)Subjects who are currently on treatment at a medical institution for a disease that may affect the study. 6)Subjects who are participating in a clinical trial or have participated in another clinical trial within 1 month before the date of consent for this study. 7)Subjects who are pregnant and those who are breastfeeding. 8)Subjects who plan to participate in another clinical trial during the study period. 9)Subjects who have difficulty in wearing the prototype device. 10)Subjects who have difficulty in wearing continuous glucose monitoring. 11)Subjects who have difficulty in blood drawing from their fingertips by themselves. 12)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath